dimaprit has been researched along with Experimental Neoplasms in 2 studies
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
Excerpt | Relevance | Reference |
---|---|---|
"-injected B16 melanoma (F1 and F10 strain) cells in Swiss albino, C57BL/6, and BALB/c mice was reduced by a single dose of histamine given 24 h before tumor cell inoculation." | 3.68 | Role of histamine in natural killer cell-mediated resistance against tumor cells. ( Asea, A; Hellstrand, K; Hermodsson, S, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hellstrand, K | 1 |
Asea, A | 1 |
Hermodsson, S | 1 |
Fray, A | 1 |
Burtin, C | 1 |
Scheinmann, P | 1 |
Lespinats, G | 1 |
Canu, P | 1 |
2 other studies available for dimaprit and Experimental Neoplasms
Article | Year |
---|---|
Role of histamine in natural killer cell-mediated resistance against tumor cells.
Topics: Animals; Cytotoxicity, Immunologic; Dimaprit; Histamine; Immunity, Cellular; Interleukin-2; Killer C | 1990 |
In vivo and in vitro anti-tumour activity of dimaprit.
Topics: Animals; Antineoplastic Agents; Cell Division; Cells, Cultured; Dimaprit; Female; In Vitro Technique | 1985 |